ICD-10 H05.832 is officially defined as "Thyroid orbitopathy, left orbit." code H05.832 is referenced in 2 tracked payer policy changes from Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code H05.832 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Independence Blue Cross added three ICD-10 diagnosis codes (H05.831, H05.832, H05.833) for thyroid orbitopathy to policy MA08.115c effective 10/01/2025. These codes specify laterality (right orbit, left orbit, bilateral) for Teprotumumab (Tepezza) claims and must be used alongside existing thyrotoxicosis codes to support medical necessity for coverage.
Independence Blue Cross added three new ICD-10 diagnosis codes (H05.831, H05.832, H05.833) for thyroid orbitopathy to policy 08.00.41c effective 10/01/2025. This is a coding update only; the coverage criteria, dosing, and medical necessity requirements for Tepezza remain unchanged. Billing teams must ensure these new codes are available in their systems and used appropriately when submitting claims for thyroid eye disease.
Watch H05.832
Get one email when a payer policy names H05.832, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.